Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Whitehawk Therapeutics, Inc. | 8,333,000 | reported | 28 Feb 2025 | tx 4+10,290,556 |
| Mirati Therapeutics, Inc. | 3,800,000 | reported | 23 Jul 2019 | tx 7+400,000−1,061,336 |
| CymaBay Therapeutics, Inc. | 250 | reported | 13 Sept 2023 | tx 7+5,226,628−3,000 |
| IMMUNOMEDICS INC | 0 | reported | 23 Oct 2020 | tx 23+10,913,476−26,771,348 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Feb 2025 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 8,333,000 | 2.40 USD | deriv |
| 13 Sept 2023 | SALE | CymaBay Therapeutics, Inc. | 950 | 1.10 USD | deriv |
| 12 Sept 2023 | PURCHASE | CymaBay Therapeutics, Inc. | 583,771 | 17.13 USD | deriv |
| 13 Sept 2023 | SALE | CymaBay Therapeutics, Inc. | 250 | 0.98 USD | deriv |
| 12 Sept 2023 | SALE | CymaBay Therapeutics, Inc. | 1,500 | 1.00 USD | deriv |
| 12 Sept 2023 | SALE | CymaBay Therapeutics, Inc. | 300 | 1.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 28,255 | 0.00 USD | deriv |
| 26 Jan 2023 | PURCHASE | CymaBay Therapeutics, Inc. | 2,142,857 | 7.00 USD | derivfirst after silence |
| 22 Nov 2021 | PURCHASE | CymaBay Therapeutics, Inc. | 2,500,000 | 4.00 USD | derivfirst after silence |
| 26 Aug 2021 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 1,911,752 | 13.08 USD | |
| 27 Aug 2021 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 17,549 | 0.00 USD | deriv |
| 23 Oct 2020 | OTHER | IMMUNOMEDICS INC | 26,250,000 | — | |
| 23 Oct 2020 | OTHER | IMMUNOMEDICS INC | 13,516 | — | |
| 23 Oct 2020 | OTHER | IMMUNOMEDICS INC | 202,614 | — | deriv |
| 23 Oct 2020 | OTHER | IMMUNOMEDICS INC | 103,718 | — | deriv |
| 01 May 2020 | PURCHASE | IMMUNOMEDICS INC | 1,750,000 | 28.50 USD | anomaly |
| 20 Mar 2020 | GRANT_AWARD | IMMUNOMEDICS INC | 100,000 | 0.00 USD | |
| 05 Dec 2019 | PURCHASE | IMMUNOMEDICS INC | 2,000,000 | 17.50 USD | first after silence |
| 23 Jul 2019 | SALE | Mirati Therapeutics, Inc. | 62,500 | 101.88 USD | |
| 07 Jun 2019 | GRANT_AWARD | IMMUNOMEDICS INC | 9,667 | 0.00 USD | |
| 07 Jun 2019 | GRANT_AWARD | IMMUNOMEDICS INC | 17,077 | 0.00 USD | deriv |
| 19 Mar 2019 | SALE | Mirati Therapeutics, Inc. | 100,000 | 73.43 USD | |
| 18 Mar 2019 | SALE | Mirati Therapeutics, Inc. | 125,000 | 76.55 USD | |
| 20 Mar 2019 | SALE | Mirati Therapeutics, Inc. | 23,781 | 72.80 USD | |
| 20 Feb 2019 | SALE | Mirati Therapeutics, Inc. | 686,820 | 73.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 26 Jan 2023.